D
David Hammond
Researcher at University of Waterloo
Publications - 203
Citations - 12096
David Hammond is an academic researcher from University of Waterloo. The author has contributed to research in topics: Medicine & Cannabis. The author has an hindex of 48, co-authored 137 publications receiving 10456 citations. Previous affiliations of David Hammond include Australian National University & Ontario Institute for Cancer Research.
Papers
More filters
Journal ArticleDOI
Health warning messages on tobacco products: a review
TL;DR: The evidence indicates that the impact of health warnings depends upon their size and design: whereas obscure text-only warnings appear to have little impact, prominent health warnings on the face of packages serve as a prominent source of health information for smokers and non-smokers, can increase health knowledge and perceptions of risk and can promote smoking cessation.
Journal ArticleDOI
Nutrition labels on pre-packaged foods: a systematic review.
TL;DR: Nutrition labels on pre-packaged foods are a cost-effective population-level intervention with unparalleled reach, however, governments will need to explore new formats and different types of information content to ensure that nutrition information is accessible and understandable.
Journal ArticleDOI
Electronic Nicotine Delivery Systems: International Tobacco Control Four-Country Survey
Sarah E. Adkison,Richard J O'Connor,Maansi Bansal-Travers,Andrew Hyland,Ron Borland,Hua-Hie Yong,K. Michael Cummings,Ann McNeill,James F. Thrasher,David Hammond,Geoffrey T. Fong +10 more
TL;DR: For example, this article found that 46.6% were aware of ENDS (U.S., UK: 73%, UK: 54%, Canada: 40%, Australia: 20%) and 2.9% were current users (39% of triers).
Journal ArticleDOI
Design and methods of the Population Assessment of Tobacco and Health (PATH) Study.
Andrew Hyland,Bridget K. Ambrose,Kevin P. Conway,Nicolette Borek,Elizabeth Lambert,Charles Carusi,Kristie Taylor,Scott Crosse,Geoffrey T. Fong,K. Michael Cummings,David B. Abrams,John P. Pierce,James D. Sargent,Karen Messer,Maansi Bansal-Travers,Raymond Niaura,Donna Vallone,David Hammond,Nahla Hilmi,Jonathan Kwan,Andrea Piesse,Graham Kalton,Sharon L. Lohr,Nick Pharris-Ciurej,Victoria Castleman,Victoria R. Green,Greta K. Tessman,Annette R. Kaufman,Charles E. Lawrence,Dana M. van Bemmel,Heather L. Kimmel,Ben Blount,Ling Yang,Barbara O'Brien,Cindy Tworek,Derek Alberding,Lynn C Hull,Yu Ching Cheng,David M Maklan,Cathy L. Backinger,Wilson M. Compton +40 more
TL;DR: The cumulative, population-based data generated over time by the PATH Study will contribute to the evidence base to inform FDA's regulatory mission under the Family Smoking Prevention and Tobacco Control Act and efforts to reduce the Nation's burden of tobacco-related death and disease.
Journal ArticleDOI
Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the International Tobacco Control (ITC) Four Country Survey
TL;DR: Smokers are not fully informed about the risks of smoking, and Warnings that are graphic, larger, and more comprehensive in content are more effective in communicating the health risks ofsmoking.